Global Self-intermittent Catheter Market Size By Type (Coated Self-intermittent Catheter, Non Coated Self-intermittent Catheter), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2...

The Global Self-intermittent Catheter Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 4.1 billion by 2031, growing at a CAGR of 7.0% during the forecast period of 2023–2031. The market is expanding due to the rising prevalence of urological disorders such as urinary incontinence, bladder dysfunction, and spinal cord injuries. Additionally, increasing awareness and patient preference for self-care, combined with technological advancements that enhance product usability and patient comfort, are propelling market growth.

Drivers:

1. Rising Incidence of Urological Disorders:

The growing global burden of chronic urological conditions such as neurogenic bladder and benign prostatic hyperplasia (BPH) has significantly boosted demand for self-intermittent catheters. These devices enable safe and efficient bladder drainage in home-care settings.

2. Aging Population and Long-term Care Needs:

As the global population ages, the demand for long-term urological management solutions has surged. Elderly patients often prefer self-intermittent catheterization due to its convenience and independence-enhancing nature.

3. Technological Advancements:

Innovations such as pre-lubricated, hydrophilic-coated, and compact catheters have significantly improved comfort, sterility, and portability, making them increasingly attractive to users and healthcare providers alike.

Restraints:

1. Risk of Urinary Tract Infections (UTIs):

Despite their convenience, improper use or reuse of self-intermittent catheters can lead to UTIs, which may deter adoption, especially in developing countries with limited access to education and hygiene resources.

2. High Cost of Advanced Catheters:

Modern self-catheterization products with advanced coatings or ergonomic features are priced higher, which may restrict adoption among economically disadvantaged populations or in cost-sensitive healthcare systems.

Opportunity:

1. Growth in Home Healthcare and Telehealth:

The expansion of remote healthcare services and a growing emphasis on home-based care present vast opportunities for market players to promote self-catheterization solutions that support patient autonomy.

2. Penetration in Emerging Markets:

Rising awareness and improving healthcare infrastructure in regions such as Asia-Pacific and Latin America offer untapped potential for market expansion through affordable and innovative product offerings.

Market by System Type Insights:

The hydrophilic-coated catheter segment led the market in 2023, driven by its superior lubricity, reduced friction, and lower risk of infection. These catheters require minimal preparation and are ideal for patients performing intermittent catheterization multiple times a day. Meanwhile, non-coated catheters remain popular in low-resource settings due to their affordability but are gradually declining in market share due to hygiene concerns.

Market by End-use Insights:

The homecare segment dominated in 2023, accounting for the highest revenue share. With increased training support from healthcare providers and user-friendly designs, patients are increasingly shifting to self-catheterization at home, reducing dependence on hospital visits. The hospitals and clinics segment is expected to witness stable growth, especially in post-operative care and for patients undergoing urodynamic evaluations.

Market by Regional Insights:

North America led the global market in 2023, supported by favorable reimbursement policies, a high prevalence of spinal cord injuries, and strong healthcare infrastructure. Europe follows closely, with growing geriatric populations and public health initiatives promoting self-management. However, Asia-Pacific is expected to grow at the fastest rate due to increasing healthcare investments, urbanization, and awareness campaigns around bladder health and hygiene.

Competitive Scenario:

Leading players in the Global Self-intermittent Catheter Market include Hollister Incorporated, B. Braun Melsungen AG, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Cure Medical, Medical Technologies of Georgia, and Teleflex Incorporated. These companies are focusing on product innovation, regulatory approvals, strategic partnerships, and global expansion to maintain competitiveness. Notable developments include:

2023: Coloplast launched its new compact hydrophilic catheter designed for enhanced portability and discretion.

2024: B. Braun Melsungen AG expanded its production capacity in Europe to meet the rising demand for self-intermittent products.

2025: Hollister Incorporated announced a collaboration with digital health platforms to offer virtual catheterization training and monitoring tools.

Scope of Work – Global Self-intermittent Catheter Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.1 billion

CAGR (2023–2031) 7.0%

Market Segments By System Type (Hydrophilic-coated, Non-coated), End-use (Homecare, Hospitals & Clinics), Region

Growth Drivers Aging population, rising urological disorders, and technological advancements

Opportunities